SEC form · 8-K · Item 2.02
Earnings releases filed with the SEC today (8-K Item 2.02)
8-KWhen a company announces its quarterly or annual results, it furnishes the release to the SEC on Form 8-K under Item 2.02, Results of Operations and Financial Condition. These are the latest ones Earnings Feed has picked up from EDGAR.
Releases
40
Latest sample
Companies
40
Latest
Nov 16, 7:35 AM ET
8-K · Item 2.02
Latest earnings releases
- 8-KEDBLEdible Garden AG Inc: reports results for quarter ended Sep 30, 2026Edible Garden AG Inc · Also Item 9.01SEC(opens sec.gov)
- 8-KVIDAVIDA Global Inc.: Reports results for quarter ended Sep 30, 2026VIDA Global Inc. · Also Items 7.01, 9.01SEC(opens sec.gov)
- 8-KMBRXMoleculin Biotech: reports Q3 2026 financial resultsMoleculin Biotech, Inc. · Also Item 9.01SEC(opens sec.gov)
- 8-KMPLTMapLight Therapeutics, Inc.: reports Q3 2026 results and updates presentationMapLight Therapeutics, Inc. · Also Items 7.01, 9.01SEC(opens sec.gov)
- 8-KXTNDXtend AI Robotics, Inc.: reports results for quarter ended Sep 30, 2026Xtend AI Robotics, Inc. · Also Item 9.01SEC(opens sec.gov)
- 8-KLRMRLarimar Therapeutics, Inc.: reports Q3 2026 resultsLarimar Therapeutics, Inc. · Also Item 9.01SEC(opens sec.gov)
- 8-KPRLDPrelude Therapeutics Inc: reports results for quarter ended Sep 30, 2026Prelude Therapeutics Inc · Also Items 7.01, 9.01SEC(opens sec.gov)
- 8-KIVVDInvivyd, Inc.: reports results for quarter ended Sep 30, 2026Invivyd, Inc. · Also Item 9.01SEC(opens sec.gov)
- 8-KCYPHCypherpunk Technologies Inc.: reports quarter ended Sep 30, 2026 resultsCYPHERPUNK TECHNOLOGIES INC. · Also Item 9.01SEC(opens sec.gov)
- 8-KXTNTXtant Medical: reports 3rd quarter 2026 results and board-led strategic reviewXtant Medical Holdings, Inc. · Also Item 9.01SEC(opens sec.gov)
- 8-KAIRJAirJoule Technologies Corp.: reports Q3 2026 results and appoints directorAirJoule Technologies Corp. · Also Items 5.02, 9.01SEC(opens sec.gov)
- 8-KMTRIInMed Pharmaceuticals: completes acquisition of MentariInMed Pharmaceuticals Inc. · Also Items 2.01, 9.01SEC(opens sec.gov)
- 8-KLXEOLexeo Therapeutics: reports results for 3 and 9 months ended Sep 30, 2026Lexeo Therapeutics, Inc. · Also Items 7.01, 8.01, 9.01SEC(opens sec.gov)
- 8-KELWTElauwit Connection: reports results for quarter ended Sep 30, 2026Elauwit Connection, Inc. · Also Item 9.01SEC(opens sec.gov)
- 8-KTILInstil Bio, Inc.: reports results for quarter ended Sep 30, 2026Instil Bio, Inc. · Also Item 9.01SEC(opens sec.gov)
- 8-KVYCOVycor Medical Inc: reports results for three and nine months ended Sep 30, 2026VYCOR MEDICAL INC · Also Item 9.01SEC(opens sec.gov)
- 8-KBXDCBlackstone Digital Infrastructure Trust Inc.: reports 3rd quarter 2026 resultsBlackstone Digital Infrastructure Trust Inc. · Also Items 7.01, 9.01SEC(opens sec.gov)
- 8-KARMKAramark: reports results for quarter and fiscal year ended Oct 2, 2026Aramark · Also Item 9.01SEC(opens sec.gov)
- 8-KODYSOdysight.ai Inc.: reports results for 9 months ended Sep 30, 2026Odysight.ai Inc. · Also Item 9.01SEC(opens sec.gov)
- 8-KQINDQuality Industrial Corp.: reports Q3 2026 resultsQuality Industrial Corp. · Also Item 9.01SEC(opens sec.gov)
- 8-KCNSYCerenome, Inc.: reports Q3 2026 resultsCERENOME, INC. · Also Item 9.01SEC(opens sec.gov)
- 8-KFFRFF EAI Robotics Ecosystem Inc.: reports results for quarter ended Sep 30, 2026FF EAI Robotics Ecosystem Inc. · Also Items 7.01, 9.01SEC(opens sec.gov)
- 8-KAKTXAkari Therapeutics Plc: reports Q3 2026 financial resultsAkari Therapeutics Plc · Also Item 9.01SEC(opens sec.gov)
- 8-KSPRUSpruce Power Holding Corporation: reports Q3 2026 resultsSPRUCE POWER HOLDING CORP · Also Item 9.01SEC(opens sec.gov)
- 8-KSPCEVirgin Galactic: open market sale agreement and planned note exchangesVirgin Galactic Holdings, Inc · Also Items 7.01, 8.01, 9.01SEC(opens sec.gov)
- 8-KPROPPrairie Operating Co.: announces third quarter 2026 resultsPrairie Operating Co. · Also Item 9.01SEC(opens sec.gov)
- 8-KRNAAtrium Therapeutics, Inc.: reports quarter ended Sep 30, 2026 resultsAtrium Therapeutics, Inc. · Also Item 9.01SEC(opens sec.gov)
- 8-KTACTTransAct Technologies Inc: reports preliminary results for Sep 30, 2026TRANSACT TECHNOLOGIES INC · Also Item 9.01SEC(opens sec.gov)
- 8-KELDNEledon Pharmaceuticals, Inc.: reports quarter ended Sep 30, 2026Eledon Pharmaceuticals, Inc. · Also Item 9.01SEC(opens sec.gov)
- 8-KSHIMShimmick Corp: reports Q3 2026 resultsShimmick Corp · Also Item 9.01SEC(opens sec.gov)
- 8-KOPNWOpenWorld, Inc.: reports Q3 2026 resultsOpenWorld, Inc. · Also Item 9.01SEC(opens sec.gov)
- 8-KNUWENuwellis, Inc.: reports Q3 2026 financial resultsNuwellis, Inc. · Also Item 9.01SEC(opens sec.gov)
- 8-KSLNSilence Therapeutics plc: reports Q3 2026 resultsSilence Therapeutics plc · Also Item 9.01SEC(opens sec.gov)
- 8-KIMNNImunon: reports Q3 2026 financial resultsImunon, Inc. · Also Item 9.01SEC(opens sec.gov)
- 8-KSGMTSagimet Biosciences Inc.: reports Q3 2026 financial resultsSagimet Biosciences Inc. · Also Items 7.01, 9.01SEC(opens sec.gov)
- 8-KEROCERock, Inc.: reports results for quarter ended Sep 30, 2026ERock, Inc. · Also Item 9.01SEC(opens sec.gov)
- 8-KFBYDFalcon's Beyond Global, Inc.: reports results for quarter ended Sep 30, 2026Falcon's Beyond Global, Inc. · Also Item 9.01SEC(opens sec.gov)
- 8-KCAPSCapstone Holding Corp.: reports Q3 2026 results and furnishes presentationCapstone Holding Corp. · Also Items 7.01, 9.01SEC(opens sec.gov)
- 8-KDPCDPC Holdings PLCAlso Item 9.01SEC(opens sec.gov)
- 8-KABSIAbsci Corp: reports Q3 2026 financial resultsAbsci Corp · Also Items 8.01, 9.01SEC(opens sec.gov)
Headlines are AI-written summaries of each release; check the filing. Original 8-Ks only: an 8-K/A usually adds to a release already listed.
Reference
What Item 2.02 requires
What triggers it
A public announcement of material, nonpublic results for a completed quarter or year. The company gives the date of the release, names it, and attaches its text as an exhibit (Item 2.02(a)). A results call within 48 hours of a release that was already furnished does not need its own 8-K (Item 2.02(b)).
Furnished, not filed
Item 2.02 information is furnished: it is not subject to Section 18 of the Exchange Act unless the company says it is filed or brings it into another filing (General Instruction B.2).
When it is due
Within four business days of the announcement, like most 8-K items (General Instruction B.1). Results first reported in a 10-Q or 10-K do not need an Item 2.02 8-K.
Source: SEC Form 8-K and its General Instructions.
Every 8-K, latest first8-K filings explainedFollow 8-Ks with the SEC’s own feeds
Forms, guides and tools